Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001209191-22-046392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-17 | 2022-08-15 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $25.58 | -11.0K | 673.1K | -2% | -$281.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-15 | S | D | 608 | $26.30 | 672,456 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $26.22 to $26.33. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2022-08-15 | S | D | 10,392 | $25.54 | 673,064 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $25.21 to $26.20. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |